218 related articles for article (PubMed ID: 10524684)
1. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
[TBL] [Abstract][Full Text] [Related]
2. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
3. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.
Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T
Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313
[TBL] [Abstract][Full Text] [Related]
4. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells.
Vega-Ostertag M; Liu X; Kwan-Ki H; Chen P; Pierangeli S
Br J Haematol; 2006 Oct; 135(2):214-9. PubMed ID: 16965389
[TBL] [Abstract][Full Text] [Related]
6. Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome.
Amengual O; Atsumi T; Koike T
Clin Immunol; 2004 Aug; 112(2):144-9. PubMed ID: 15240157
[TBL] [Abstract][Full Text] [Related]
7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
9. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
[TBL] [Abstract][Full Text] [Related]
10. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity.
Yang YH; Chang CJ; Chuang YH; Hsu HY; Chen PP; Chiang BL
Rheumatology (Oxford); 2010 Jan; 49(1):34-42. PubMed ID: 19920091
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
[TBL] [Abstract][Full Text] [Related]
12. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
13. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
16. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
17. [A study on antiprothrombin antibodies in antiphospholipid syndrome].
Ieko M; Triplett DA; Kohno M; Ohmoto A; Notoya A; Sawada K; Koike T
Rinsho Ketsueki; 1997 May; 38(5):426-32. PubMed ID: 9194388
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in antiphospholipid syndrome].
Kaburaki J; Kuwana M; Kameda H; Takeuchi T; Okada J; Katayama M; Yoshida S; Ikeda Y
Rinsho Ketsueki; 2005 Jan; 46(1):19-21. PubMed ID: 16708913
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
